These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8941198)
81. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program. Alberg AJ; Stashefsky Margalit R; Burke A; Rasch KA; Stewart N; Kline JA; Ernst PA; Avey A; Hoffman SC Addict Behav; 2004 Dec; 29(9):1763-78. PubMed ID: 15530720 [TBL] [Abstract][Full Text] [Related]
82. The use of nicotine patches with minimal intervention. Jolicoeur DG; Ahluwalia JS; Richter KP; Mosier M; Harris KJ; Gibson C; Moranetz CA Prev Med; 2000 Jun; 30(6):504-12. PubMed ID: 10901493 [TBL] [Abstract][Full Text] [Related]
83. Transdermal nicotine patches do not cause clinically significant gastroesophageal reflux or esophageal motor disorders. Wright RA; Goldsmith LJ; Ameen V; D'Angelo A; Kirby SL; Prakash S Nicotine Tob Res; 1999 Dec; 1(4):371-4. PubMed ID: 11072435 [TBL] [Abstract][Full Text] [Related]
84. Effects of stress on circulating nicotine and cotinine levels and in vitro nicotine metabolism in the rat. Winders SE; Grunberg NE; Benowitz NL; Alvares AP Psychopharmacology (Berl); 1998 Jun; 137(4):383-90. PubMed ID: 9676899 [TBL] [Abstract][Full Text] [Related]
86. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Thomas GA; Rhodes J; Ragunath K; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):769-76. PubMed ID: 8864674 [TBL] [Abstract][Full Text] [Related]
87. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993 [TBL] [Abstract][Full Text] [Related]
88. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. White HK; Levin ED Psychopharmacology (Berl); 1999 Apr; 143(2):158-65. PubMed ID: 10326778 [TBL] [Abstract][Full Text] [Related]
89. Effects of transdermal nicotine on cognitive performance in Down's syndrome. Seidl R; Tiefenthaler M; Hauser E; Lubec G Lancet; 2000 Oct; 356(9239):1409-10. PubMed ID: 11052587 [TBL] [Abstract][Full Text] [Related]
90. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Kleykamp BA; Jennings JM; Sams C; Weaver MF; Eissenberg T Exp Clin Psychopharmacol; 2008 Apr; 16(2):99-112. PubMed ID: 18489014 [TBL] [Abstract][Full Text] [Related]
91. Liver Donation After Brain Death Following Intentional Ingestion of 99% E-Cigarette Liquid Nicotine 10 mL. Lee J; You Y; Park JS; Min JH; Yoo I; Jeong W; Cho Y; Ryu S; Kim S; Cho SU; Oh SK; Lee J; Ahn HJ; Jung SM Exp Clin Transplant; 2020 Feb; 18(1):120-122. PubMed ID: 29911961 [TBL] [Abstract][Full Text] [Related]
92. Effects of a single transdermal nicotine dose on cognitive performance in adults with Down syndrome. Bernert G; Sustrova M; Sovcikova E; Seidl R; Lubec G J Neural Transm Suppl; 2001; (61):237-45. PubMed ID: 11771747 [TBL] [Abstract][Full Text] [Related]
93. Precision treatment with nicotine in autosomal dominant sleep-related hypermotor epilepsy (ADSHE): An observational study of clinical outcome and serum cotinine levels in 17 patients. Brodtkorb E; Myren-Svelstad S; Knudsen-Baas KM; Nakken KO; Spigset O Epilepsy Res; 2021 Dec; 178():106792. PubMed ID: 34763266 [TBL] [Abstract][Full Text] [Related]
94. Prolonged absorption with development of tolerance to toxic effects after cutaneous exposure to nicotine. Benowitz NL; Lake T; Keller KH; Lee BL Clin Pharmacol Ther; 1987 Jul; 42(1):119-20. PubMed ID: 3595064 [TBL] [Abstract][Full Text] [Related]
95. Acute nicotine poisoning: a rare cause of paroxysmal atrial fibrillation. Cózar-Llistó A; Pérez-Torres M; de Andrés-Moro F; Mencías-Rodríguez E Emergencias; 2019 Oct; 31(5):363. PubMed ID: 31625312 [No Abstract] [Full Text] [Related]
96. Acrylic matrix type nicotine transdermal patches: in vitro evaluations and batch-to-batch uniformity. Pongjanyakul T; Prakongpan S; Priprem A Drug Dev Ind Pharm; 2003 Sep; 29(8):843-53. PubMed ID: 14570305 [TBL] [Abstract][Full Text] [Related]
97. Permeation studies comparing cobra skin with human skin using nicotine transdermal patches. Pongjanyakul T; Prakongpan S; Priprem A Drug Dev Ind Pharm; 2000 Jun; 26(6):635-42. PubMed ID: 10826111 [TBL] [Abstract][Full Text] [Related]
98. Transdermal patch drug delivery interactions with exercise. Lenz TL; Gillespie N Sports Med; 2011 Mar; 41(3):177-83. PubMed ID: 21395361 [TBL] [Abstract][Full Text] [Related]
100. Prolonged exposure to transdermal nicotine improves memory in male mice, but impairs biochemical parameters in male and female mice. Nieradko-Iwanicka B; Pietraszek D; Pośnik K; Borzęcki A Ann Agric Environ Med; 2019 Mar; 26(1):62-66. PubMed ID: 30922031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]